Paragon Bioservices, Inc.
Craig Wells has over 17 years of experience in the pharmaceutical and biotechnology sectors. Currently serving as a Fill Finish Technician at Paragon Bioservices, Inc. since November 2016, Craig has developed expertise in manufacturing processes. Prior to this role, Craig worked as a Chemical Operator at Pixelligent Technologies from December 2011 to September 2016, and as a Senior Operator at Shire Pharmaceuticals from July 2005 to October 2011, gaining valuable experience in various operational capacities within the industry.
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.